Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 67 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 9265804

    Compositions and methods for treatment of cancer using bacteria

    Decoy Biosystems, Inc. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted

  2. US 9266960

    Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted

  3. US 9265749

    Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders

    Patara Pharma, LLC · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted

  4. US 9267151

    STXBP1 overexpressing mouse and its uses in screening of treatments for neuropsychiatric illness

    UNIVERSIDAD DEL PAÍS VASCO / EUSKAL HERRIKO UNIBERTSITATEA · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted

  5. US 9248131

    Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted

  6. US 9248172

    Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

    University of Connecticut Health Center · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted

  7. US 9249424

    Intranasal delivery of AAV encoding therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases

    Regents of the University of Minnesota · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted

  8. US 9241998

    Methods and compositions for treatment of cancer using oncolytic RSV activity

    The Board of Regents of the University of Texas System · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted

  9. US 9244082

    Detection and treatment of LRP4-associated neurotransmission disorders

    Georgia Regents Research Institute, Inc. · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted

  10. US 9243295

    Antipsychotic treatment based on DRD2 or ANKK1 SNP genotype

    VANDA PHARMACEUTICALS INC. · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted

  11. US 9238838

    Microrna patterns for the diagnosis, prognosis and treatment of melanoma

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted

  12. US 9238069

    Method of sensitizing cancer cells to the cytotoxic effects of death receptor ligands in cancer treatment

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted

  13. US 9233068

    Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders

    The Regents of the University of California · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted

  14. US 9233121

    Compositions and methods for the treatment of cancer

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted

  15. US 9226930

    1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders

    Addex Pharma, S.A. · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted

  16. US 9226955

    Allogeneic autophagosome-enriched composition for the treatment of disease

    Providence Health & Services—Oregon · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted

  17. US 9226910

    Treatment for obesity

    Jazz Pharmaceuticals International III Limited · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted

  18. US 9221800

    Isoxazole treatments for diabetes

    The Board of Regents of the University of Texas System · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted

  19. ZA 201308176

    THERAPEUTIC TREATMENT

    ASTRAZENECA AB [SE] · Granted Dec 23, 2015 · Expires Dec 18, 2035

    granted

  20. US 9211419

    Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficacy

    The Board of Regents of the University of Texas System · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  21. US 9212212

    Targeting complement factor H for treatment of diseases

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  22. US 9205131

    Use of IL-17D for the treatment and prevention of cancers

    The Regents of the University of California · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted

  23. US 9205048

    Controlled release antimicrobial compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted

  24. US 9198921

    Non-hormonal steroid modulators of NF-κB for treatment of disease

    ReveraGen BioPharma, Inc. · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.